As of 2024-12-15, the EV/EBITDA ratio of FibroGen Inc (FGEN) is 0.07. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. FGEN's latest enterprise value is -6.48 mil USD. FGEN's TTM EBITDA according to its financial statements is -90.19 mil USD. Dividing these 2 quantities gives us the above FGEN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.8x - 15.9x | 14.8x |
| Forward P/E multiples | 15.0x - 15.5x | 15.2x |
| Fair Price | (13.03) - (13.48) | (13.07) |
| Upside | -4013.5% - -4147.9% | -4027.0% |
| Date | EV/EBITDA |
| 2024-12-13 | 0.07 |
| 2024-12-12 | 0.06 |
| 2024-12-11 | 0.05 |
| 2024-12-10 | 0.04 |
| 2024-12-09 | 0.04 |
| 2024-12-06 | 0.06 |
| 2024-12-05 | -0.01 |
| 2024-12-04 | -0.01 |
| 2024-12-03 | -0.01 |
| 2024-12-02 | -0.03 |
| 2024-11-29 | -0.03 |
| 2024-11-27 | 0.01 |
| 2024-11-26 | 0.01 |
| 2024-11-25 | 0.01 |
| 2024-11-22 | 0.00 |
| 2024-11-21 | 0.01 |
| 2024-11-20 | 0.05 |
| 2024-11-19 | 0.05 |
| 2024-11-18 | 0.07 |
| 2024-11-15 | 0.07 |
| 2024-11-14 | 0.03 |
| 2024-11-13 | 0.07 |
| 2024-11-12 | 0.01 |
| 2024-11-11 | 0.07 |
| 2024-11-08 | 0.08 |
| 2024-11-07 | 0.09 |
| 2024-11-06 | 0.10 |
| 2024-11-05 | 0.10 |
| 2024-11-04 | 0.08 |
| 2024-11-01 | 0.09 |
| 2024-10-31 | 0.11 |
| 2024-10-30 | 0.09 |
| 2024-10-29 | 0.10 |
| 2024-10-28 | 0.11 |
| 2024-10-25 | 0.10 |
| 2024-10-24 | 0.09 |
| 2024-10-23 | 0.09 |
| 2024-10-22 | 0.05 |
| 2024-10-21 | 0.03 |
| 2024-10-18 | 0.01 |
| 2024-10-17 | 0.00 |
| 2024-10-16 | 0.02 |
| 2024-10-15 | 0.05 |
| 2024-10-14 | 0.06 |
| 2024-10-11 | 0.04 |
| 2024-10-10 | 0.07 |
| 2024-10-09 | 0.08 |
| 2024-10-08 | 0.08 |
| 2024-10-07 | 0.06 |
| 2024-10-04 | 0.03 |